This clinical trial compares two smartphone applications, called Actify! (A \& B) for improving smoking cessation outcomes in individuals who smoke. Actify! A is an app grounded in behavioral activation therapy, an evidence-based treatment for depression that can also be used to modify health behaviors such as smoking. The Actify! B app provides evidence-based tobacco cessation strategies based on current clinical guidelines.
Age 18 or older
Currently smoke, averaging at least 5 cigarettes/day for the last 30 days
Interested in quitting smoking in the next 30 days
Experience downloading and using one or more apps on their smartphone
Self-report of currently receiving behavioral treatment for depression (e.g., psychotherapy or counseling, web- or app-based interventions); current use of pharmacotherapy for depression or for other mental health conditions that are not otherwise excluded is allowable (e.g., benzodiazepines, anticonvulsants, opioid agonists, antipsychotics)
Severe depression (PHQ-9 ≥ 20)
Current suicidal ideation reported on the PHQ-9
History of a suicide attempt
Parallel
Smartphone app-based Intervention (Actify! A app)
BehavioralUse Actify! A app
Smartphone app-based Intervention (Actify! B app)
BehavioralUse Actify! B app
Health Promotion and Education
Other interventionReceive motivational messages and smoking cessation information via text messages
Survey Administration
Other interventionAncillary studies
Self-reported 30-day point prevalence abstinence (PPA) from cigarette smoking
Percentage of participants self-reporting no smoking over the previous 30 days
Biochemically-confirmed 30-day PPA from cigarette smoking
Percentage of participants reporting no smoking over the previous 30 days, confirmed via carbon monoxide testing
Self-reported 7-day PPA from cigarette smoking
Percentage of participants reporting no cigarette smoking over the prior 7 days
Self-reported 7-day PPA from cigarette smoking
Percentage of participants reporting no cigarette smoking over the prior 7 days
Self-reported 7-day PPA from use of all nicotine/tobacco products except Food and Drug Administration (FDA)-approved medications
Percentage of participants reporting no smoking over the prior 7 days and no use of any other nicotine/tobacco product except FDA-approved medications (e.g, nicotine patch or gum)
Click on the lead sponsor to view all of their trials.
Fred Hutchinson Cancer Center
Lead sponsor
National Institute on Drug Abuse (NIDA)
Collaborator
This trial is not recruiting at the moment. You can still explore other options:
